MERUS N.V.

Profile

Company Names

MERUS N.V.

Addresses

YALELAAN 62, 3584 CM UTRECHT, P7 3584 CM

Phone Numbers

31 030 253 8800

 

Entity Type:

OTHER

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

NETHERLANDS

Total Amount Raised:

$150,799,946.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2018-12-20 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
2
2018-02-15 
$55,799,946.00 
$55,799,946.00 
$0.00 
Equity 
1
2017-01-23 
$80,000,000.00 
$80,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LEX 
 
BAKKER 
EXECUTIVE OFFICER
MERUS N.V.
WOLFGANG 
 
BERTHOLD 
DIRECTOR
MERUS N.V.
LIONEL 
M.S. 
CARNOT 
DIRECTOR
MERUS N.V.
JOHN 
 
CROWLEY 
EXECUTIVE OFFICER
WEATHER ANALYTICS, LLC   |  COTA, INC.   |  AMICUS THERAPEUTICS INC   |  MERUS N.V.   |  ENTRADA THERAPEUTICS, INC.
JOHN 
P. 
DE KONING 
DIRECTOR
MERUS N.V.
JOHN 
 
DE KRUIF 
EXECUTIVE OFFICER
MERUS N.V.
RUSSELL 
 
GREIG 
DIRECTOR
TIGENIX NV   |  MERUS N.V.   |  BIOMX INC.
MARK 
T. 
IWICKI 
DIRECTOR
MERUS N.V.   |  AIMMUNE THERAPEUTICS, INC.
LEN 
 
KANAVY 
DIRECTOR
MERUS N.V.
HUI 
 
LIU 
EXECUTIVE OFFICER
HYCOR HOLDINGS INC.   |  MERUS N.V.   |  DEEPER NETWORK INC.   |  RALLYBIO CORP
TON 
 
LOGTENBERG 
EXECUTIVE OFFICER, DIRECTOR
MERUS N.V.
SHELLEY 
 
MARGETSON 
EXECUTIVE OFFICER
MERUS N.V.
ANAND 
 
MEHRA 
DIRECTOR
MARINUS PHARMACEUTICALS INC   |  VICEPT THERAPEUTICS, INC.   |  AERIE PHARMACEUTICALS INC   |  NEXTWAVE PHARMACEUTICALS INC   |  SPARK THERAPEUTICS, INC.   |  ACLARIS THERAPEUTICS, INC.   |  FIRST AID BEVERAGES, INC.   |  SOFINNOVA VENTURE PARTNERS X, L.P.   |  MERUS N.V.   |  AMPLYX PHARMACEUTICALS, INC.
JACK 
B. 
NIELSEN 
DIRECTOR
NEOMEND INC   |  REATA PHARMACEUTICALS INC   |  MERUS N.V.   |  CRINETICS PHARMACEUTICALS, INC.
GREGORY 
D. 
PERRY 
DIRECTOR
ELEVEN BIOTHERAPEUTICS, INC.   |  MERUS N.V.   |  KALA PHARMACEUTICALS, INC.   |  KALA BIO, INC.
PETER 
 
SILVERMAN 
EXECUTIVE OFFICER
MERUS N.V.
L. 
ANDRES 
SIRULNIK 
EXECUTIVE OFFICER
MERUS N.V.
MARK 
 
THROSBY 
EXECUTIVE OFFICER
MERUS N.V.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-01-02
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-12-20 
2018-02-28
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-02-15 
2017-01-24
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-01-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#